Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption

Molecular Neurobiology

Volumn 54, Issue 6, 2017, Pages 4723-4737

  Souza, Priscila S ^a   Gonçalves, Elaine D ^b   Pedroso, Giulia S ^a   Farias, Hemelin R ^a   Junqueira, Stella C ^b   Marcon, Rodrigo ^c   Tuon, Talita ^a   Cola, Maíra ^b   Silveira, Paulo C L ^a   Santos, Adair R ^b   Calixto, João B ^c   Souza, Cláudio T ^a   de Pinho, Ricardo A ^a   Dutra, Rafael C ^b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c Center of Innovation and Preclinical Studies CIEnP   (Brazil)

Author keywords

Experimental autoimmune encephalomyelitis; Inflammatory mediators; Multiple sclerosis; Physical exercise

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR; ANTIOXIDANT; AUTACOID; BIOLOGICAL MARKER; TIGHT JUNCTION PROTEIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDURANCE TRAINING; EXERCISE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RESISTANCE TRAINING; SIGNAL TRANSDUCTION; SPINAL CORD; SPLEEN CELL; TIGHT JUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; ENDURANCE; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOID TISSUE; METABOLISM; PATHOLOGY; PERMEABILITY; REGULATORY T LYMPHOCYTE; SEVERITY OF ILLNESS INDEX;

ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD-BRAIN BARRIER; CELL ADHESION MOLECULES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LYMPHOID TISSUE; MICE, INBRED C57BL; OXIDATIVE STRESS; PERMEABILITY; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; TIGHT JUNCTION PROTEINS;

EID: 84979598062     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-016-0014-0     Document Type: Article

References (67)

1. McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8(9):913–919
2. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9(6):393–407
3. Alvarez JI, Cayrol R, Prat A (2011) Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta 1812(2):252–264
4. Costanza M, Colombo MP, Pedotti R (2012) Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci 13(11):15107–15125. doi:10.3390/ijms131115107
5. Ley K (1996) Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32(4):733–742
6. Frijns CJ, Kappelle LJ (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33(8):2115–2122
7. Dore-Duffy P, Washington R, Dragovic L (1993) Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. Adv Exp Med Biol 331:243–248
8. Lewen A, Matz P, Chan PH (2000) Free radical pathways in CNS injury. J Neurotrauma 17(10):871–890
9. Korhonen R, Lahti A, Kankaanranta H, Moilanen E (2005) Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 4(4):471–479
10. Vaz AR, Silva SL, Barateiro A, Fernandes A, Falcao AS, Brito MA, Brites D (2011) Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin. Exp Neurol 229(2):381–390. doi:10.1016/j.expneurol.2011.03.004
11. van der Goes A, Wouters D, van der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD et al (2001) Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J 15(10):1852–1854
12. Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, Dopp ED, Dijkstra CD et al (2006) Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol 177(4):2630–2637
13. Aydin O, Ellidag HY, Eren E, Kurtulus F, Yaman A, Yilmaz N (2014) Ischemia modified albumin is an indicator of oxidative stress in multiple sclerosis. Biochem Med (Zagreb) 24(3):383–389. doi:10.11613/BM.2014.041
14. Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14(2):183–193. doi:10.1016/S1474-4422(14)70256-X
15. Kileff J, Ashburn A (2005) A pilot study of the effect of aerobic exercise on people with moderate disability multiple sclerosis. Clin Rehabil 19(2):165–169
16. Motl RW (2011) Physical activity and irreversible disability in multiple sclerosis. Exerc Sport Sci Rev 38(4):186–191
17. Dalgas U, Stenager E (2012) Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis? Ther Adv Neurol Disord 5(2):81–95. doi:10.1177/1756285611430719
18. Klaren RE, Motl RW, Woods JA, Miller SD (2014) Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis). J Neuroimmunol 274(1-2):14–19. doi:10.1016/j.jneuroim.2014.06.014
19. Le Page C, Ferry A, Rieu M (1994) Effect of muscular exercise on chronic relapsing experimental autoimmune encephalomyelitis. J Appl Physiol 77(5):2341–2347
20. Le Page C, Bourdoulous S, Beraud E, Couraud PO, Rieu M, Ferry A (1996) Effect of physical exercise on adoptive experimental auto-immune encephalomyelitis in rats. Eur J Appl Physiol Occup Physiol 73(1-2):130–135
21. Figueiredo CP, Pamplona FA, Mazzuco TL, Aguiar AS Jr, Walz R, Prediger RD (2010) Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases. Behav Pharmacol 21(5-6):394–408. doi:10.1097/FBP.0b013e32833c8544
22. Gomez-Pinilla F, Ying Z, Roy RR, Molteni R, Edgerton VR (2002) Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity. J Neurophysiol 88(5):2187–2195
23. Navarro A, Gomez C, Lopez-Cepero JM, Boveris A (2004) Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am J Physiol Regul Integr Comp Physiol 286(3):R505–R511
24. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M et al (2007) Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 27(20):5291–5300
25. Aguiar AS Jr, Boemer G, Rial D, Cordova FM, Mancini G, Walz R, de Bem AF, Latini A et al (2010) High-intensity physical exercise disrupts implicit memory in mice: involvement of the striatal glutathione antioxidant system and intracellular signaling. Neuroscience 171(4):1216–1227
26. Motl RW, Pilutti LA (2012) The benefits of exercise training in multiple sclerosis. Nat Rev Neurol 8(9):487–497. doi:10.1038/nrneurol.2012.136
27. Bernardes D, Brambilla R, Bracchi-Ricard V, Karmally S, Dellarole A, Carvalho-Tavares J, Bethea JR (2015) Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis. J Neurochem. doi:10.1111/jnc.13354
28. Bernardes D, Oliveira-Lima OC, Silva TV, Faraco CC, Leite HR, Juliano MA, Santos DM, Bethea JR et al (2013) Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise. J Neuroimmunol 264(1-2):24–34. doi:10.1016/j.jneuroim.2013.08.014
29. Kalron A, Nitzani D, Magalashvili D, Dolev M, Menascu S, Stern Y, Rosenblum U, Pasitselsky D et al (2015) A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort. BMC Neurol 15:21. doi:10.1186/s12883-015-0281-9
30. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421–431
31. Bannister JV, Calabrese L (1987) Assays for superoxide dismutase. Methods Biochem Anal 32:279–312
32. Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121
33. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74(1):214–226
34. He Y, Du M, Gao Y, Liu H, Wang H, Wu X, Wang Z (2013) Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One 8(10):e76495. doi:10.1371/journal.pone.0076495
35. Larochelle C, Alvarez JI, Prat A (2011) How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett 585(23):3770–3780. doi:10.1016/j.febslet.2011.04.066
36. Li B, Cui W, Liu J, Li R, Liu Q, Xie XH, Ge XL, Zhang J et al (2013) Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol 250:239–249. doi:10.1016/j.expneurol.2013.10.002
37. Witherick J, Wilkins A, Scolding N, Kemp K (2010) Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Autoimmune Dis 2011:164608. doi:10.4061/2011/164608
38. Giudice A, Arra C, Turco MC (2010) Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol Biol 647:37–74. doi:10.1007/978-1-60761-738-9_3
39. Johnson DA, Johnson JA (2015) Nrf2—a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88(Pt B):253–267. doi:10.1016/j.freeradbiomed.2015.07.147
40. Bomprezzi R (2015) Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord 8(1):20–30. doi:10.1177/1756285614564152
41. Fischer HJ, Schweingruber N, Luhder F, Reichardt HM (2013) The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis. Mol Cell Endocrinol 380(1-2):99–107. doi:10.1016/j.mce.2013.04.001
42. Boroujerdi A, Welser-Alves JV, Milner R (2013) Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the alpha5beta1 integrin. Exp Neurol 250:43–51. doi:10.1016/j.expneurol.2013.09.009
43. Rossi S, Furlan R, De Chiara V, Musella A, Lo Giudice T, Mataluni G, Cavasinni F, Cantarella C et al (2009) Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis. Neurobiol Dis 36(1):51–59
44. Benson C, Paylor JW, Tenorio G, Winship I, Baker G, Kerr BJ (2015) Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE). Exp Neurol 271:279–290. doi:10.1016/j.expneurol.2015.05.017
45. Link H, Xiao BG (2001) Rat models as tool to develop new immunotherapies. Immunol Rev 184:117–128
46. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL et al (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195(5):603–616
47. Sapoznikov A, Jung S (2008) Probing in vivo dendritic cell functions by conditional cell ablation. Immunol Cell Biol 86(5):409–415. doi:10.1038/icb.2008.23
48. Weiss N, Miller F, Cazaubon S, Couraud PO (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788(4):842–857
49. Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E (2008) Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol 18(11):787–793. doi:10.1016/j.euroneuro.2008.07.005
50. Tuon T, Valvassori SS, Dal Pont GC, Paganini CS, Pozzi BG, Luciano TF, Souza PS, Quevedo J et al (2014) Physical training prevents depressive symptoms and a decrease in brain-derived neurotrophic factor in Parkinson’s disease. Brain Res Bull 108:106–112. doi:10.1016/j.brainresbull.2014.09.006
51. Pryor WM, Freeman KG, Larson RD, Edwards GL, White LJ (2015) Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis. J Neurosci Res 93(5):697–706. doi:10.1002/jnr.23528
52. Miller E, Walczak A, Majsterek I, Kedziora J (2013) Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol 257(1-2):97–101. doi:10.1016/j.jneuroim.2013.02.012
53. Dasgupta A, Zheng J, Perrone-Bizzozero NI, Bizzozero OA (2013) Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis. ASN Neuro 5(1):e00111. doi:10.1042/AN20120088
54. Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X et al (2011) Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134(Pt 3):678–692. doi:10.1093/brain/awq386
55. Pareek TK, Belkadi A, Kesavapany S, Zaremba A, Loh SL, Bai L, Cohen ML, Meyer C et al (2011) Triterpenoid modulation of IL-17 and Nrf-2 expression ameliorates neuroinflammation and promotes remyelination in autoimmune encephalomyelitis. Sci Rep 1:201. doi:10.1038/srep00201
56. di Penta A, Moreno B, Reix S, Fernandez-Diez B, Villanueva M, Errea O, Escala N, Vandenbroeck K et al (2013) Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One 8(2):e54722. doi:10.1371/journal.pone.0054722
57. Li T, He S, Liu S, Kong Z, Wang J, Zhang Y (2015) Effects of different exercise durations on Keap1-Nrf2-ARE pathway activation in mouse skeletal muscle. Free Radic Res 49(10):1269–1274. doi:10.3109/10715762.2015.1066784
58. Aguiar AS, Jr., Duzzioni M, Remor AP, Tristao FS, Matheus FC, Raisman-Vozari R, Latini A, Prediger RD (2015) Moderate-intensity physical exercise protects against experimental 6-hydroxydopamine-induced hemiparkinsonism through Nrf2-antioxidant response element pathway. Neurochem Res. doi:10.1007/s11064-015-1709-8
59. Calabrese V, Boyd-Kimball D, Scapagnini G, Butterfield DA (2004) Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo 18(3):245–267
60. Carvalho AN, Lim JL, Nijland PG, Witte ME, Van Horssen J (2014) Glutathione in multiple sclerosis: more than just an antioxidant? Mult Scler 20(11):1425–1431. doi:10.1177/1352458514533400
61. Yang Y, Jiang S, Yan J, Li Y, Xin Z, Lin Y, Qu Y (2015) An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev 26(1):47–57. doi:10.1016/j.cytogfr.2014.09.002
62. Golzari Z, Shabkhiz F, Soudi S, Kordi MR, Hashemi SM (2010) Combined exercise training reduces IFN-gamma and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis. Int Immunopharmacol 10(11):1415–1419. doi:10.1016/j.intimp.2010.08.008
63. Zozulya AL, Wiendl H (2008) The role of regulatory T cells in multiple sclerosis. Nat Clin Pract Neurol 4(7):384–398. doi:10.1038/ncpneuro0832
64. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M et al (2007) A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 8(12):1380–1389. doi:10.1038/ni1541
65. McGeachy MJ, Stephens LA, Anderton SM (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25+ regulatory cells within the central nervous system. J Immunol 175(5):3025–3032
66. Feger U, Luther C, Poeschel S, Melms A, Tolosa E, Wiendl H (2007) Increased frequency of CD4 + CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 147(3):412–418. doi:10.1111/j.1365-2249.2006.03271.x
67. Haas J, Hug A, Viehover A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L et al (2005) Reduced suppressive effect of CD4 + CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol 35(11):3343–3352. doi:10.1002/eji.200526065